Document is current

Any future updates will be listed below

Impurity Profiling Method Development, Validation, and Relative Response Factor Estimation for Fluticasone Furoate and Vilanterol Trifenatate Dry Powder Inhaler Using RP-HPLC with UV/PDA Detector

Crossref DOI link: https://doi.org/10.1007/s11094-025-03433-w

Published Online: 2025-09-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark